Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg
Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III development.
Nektar Digs Into Mid-Stage Data to Establish Alopecia Efficacy of Rezpeg Read More »
